SEC Filings

SEC Filings

Filing date	Description	Form	View
Aug 29, 2018		D	View HTML 0001567619-18-001858.pdf 0001567619-18-001858.rtf 0001567619-18-001858.xls
Mar 12, 2019	25-NSE	25-NSE	View HTML 0001354457-19-000124.pdf 0001354457-19-000124.rtf
May 14, 2009	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	View HTML 0001193125-09-111036.pdf 0001193125-09-111036.rtf 0001193125-09-111036.xls
Mar 17, 2010	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	View HTML 0001193125-10-059599.pdf 0001193125-10-059599.rtf 0001193125-10-059599.xls
Sep 20, 2010	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	View HTML 0001193125-10-213123.pdf 0001193125-10-213123.rtf 0001193125-10-213123.xls
Mar 21, 2012	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	View HTML 0001193125-12-124620.pdf 0001193125-12-124620.rtf 0001193125-12-124620.xls
Mar 17, 2014	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	View HTML 0001193125-14-102597.pdf 0001193125-14-102597.rtf 0001193125-14-102597.xls
Nov 12, 2015	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	View HTML 0001193125-15-375921.pdf 0001193125-15-375921.rtf 0001193125-15-375921.xls
Mar 22, 2016	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	View HTML 0001193125-16-512223.pdf 0001193125-16-512223.rtf 0001193125-16-512223.xls
Sep 02, 2016	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	View HTML 0001193125-16-700961.pdf 0001193125-16-700961.rtf 0001193125-16-700961.xls

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE